Financials data is unavailable for this security.
View more
Year on year Jupiter Bioscience Ltd grew revenues 42.43% from 2.33bn to 3.31bn while net income improved 20.92% from 424.78m to 513.64m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in INRView more
In 2011, cash reserves at Jupiter Bioscience Ltd fell by 21.49m. Cash Flow from Financing totalled 3.95bn or 119.10% of revenues. In addition the company generated 1.18bn in cash from operations while cash used for investing totalled 5.14bn.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | -- |
---|---|
Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
Current ratio | -- |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -50.00% and -65.72%, respectively. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked below the industry average relative to its peers.
Div yield(5 year avg) | -- |
---|---|
Div growth rate (5 year) | -16.74% |
Payout ratio (TTM) | -- |
EPS growth(5 years) | -17.43 |
---|---|
EPS (TTM) vs TTM 1 year ago | -- |
More ▼